NeutralLOW severityHealthcare & Pharma78d ago

UFP Technologies VP Jason Holt sells $348,700 in company stock

UFP Technologies VP Jason Holt sells $348,700 in company stock — $UFPT one-month chart
$UFPT daily closes over the past month · Wook of Wall Street artwork from market data
WOOKAI ASSISTANTREADY
WOOK AIASK ANYTHING · NEVER ADVISES

Meet Wook AI, your friendly assistant. Ask how something works, about any company, fund or coin, or have it do the math — live figures come from this site’s own lookups, and you’ll see which ones it used.

Wook analysis

What it means

Key points
  • What to watch: This one turns on a concrete figure ($348,700); set it against the recent trend before reading it as a turning point.
  • How the stock is trading: $UFPT -1.29% in the latest session.
  • Timing: It landed before the opening bell — early risers had it with their coffee, and the next session was the first that could react.
Amount$348,700

Where the stock stands

$UFPT last changed hands at $280.32, -1.29% on the session, 17% below its 52-week high of $338.71 and 61% above its low of $173.86 — a little above the middle of the range. Over the year it has ranged 95% from low to high: a wide band, so a several-percent week is just a week. These are latest-session quotes, not live prices — the live tape is on the $UFPT page.

How much coverage it is getting

This is the only story Wook has logged on $UFPT in the last 30 days — a quiet name that just got a headline. 12 related stories from the same name or desk are listed beside this one.

The bigger picture

Healthcare stories turn on approvals, trial data and pricing: one FDA decision or trial readout can swing a single drugmaker hard, while drug-pricing policy moves the whole group at once. Wook's supply-chain scanner has Health Care reading calm today: no unusual stress in the filings and disclosures it watches.

Coming up

$UFPT earnings today. These were on the calendar before this story and are not caused by it, but the nearest is close enough that the hard numbers get the last word soon.

What to watch next

The $UFPT page has the full chart, the filings and the valuation model behind every figure here. Want the facts without the spin? Read how two or three outlets frame the same story — where they agree is the news, where they differ is the angle. And Wook AI, up top, will happily do the math — how far $UFPT sits from its high, or how this week's coverage stacks up.

How this analysis was made

Investing.com published it, and Wook filed it under Healthcare & Pharma. No strongly worded term either way, so it reads neutral at low severity — a factual headline rather than a charged one. It was matched to $UFPT. It carried $348,700, shown as published and not recalculated. The publisher gave no preview text, and nothing has been written in to fill the gap.

The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.

Discussion

No one has weighed in yet. Start the discussion on this story.

What happened after this published

Investing.com published this on August 17, 2026. $UFPT has moved -12.76% ($321.31 to $280.32). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.

Headline and link are attributed to Investing.com. Wook of Wall Street is an independent research tool and is not affiliated with Investing.com. Nothing here is financial advice or a recommendation — research and educational content only.